Hyperalgesia and NMDA Receptor Antagonist

• Status: Unknown status
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: All

Summary

NMDA receptor is administered and postoperative remote hyperalgesia is investigated.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Bundang Hospital
• Treatments: Ketamine; Magnesium Sulfate

Criteria

Inclusion Criteria:

• ASA1-2

Exclusion Criteria:

• contraindication to the study drugs